Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Net Cash Flow (2016 - 2026)

Avanos Medical's Net Cash Flow history spans 13 years, with the latest figure at $18.7 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 18.34% to $18.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$22.9 million, a 195.02% decrease, with the full-year FY2025 number at -$22.9 million, down 195.02% from a year prior.
  • Net Cash Flow hit $18.7 million in Q4 2025 for Avanos Medical, up from -$19.5 million in the prior quarter.
  • Over the last five years, Net Cash Flow for AVNS hit a ceiling of $26.9 million in Q3 2023 and a floor of -$32.9 million in Q1 2023.
  • Historically, Net Cash Flow has averaged -$790000.0 across 5 years, with a median of -$2.9 million in 2021.
  • Biggest five-year swings in Net Cash Flow: soared 1787.5% in 2022 and later tumbled 404.35% in 2023.
  • Tracing AVNS's Net Cash Flow over 5 years: stood at $21.6 million in 2021, then tumbled by 68.06% to $6.9 million in 2022, then tumbled by 404.35% to -$21.0 million in 2023, then surged by 209.05% to $22.9 million in 2024, then decreased by 18.34% to $18.7 million in 2025.
  • Business Quant data shows Net Cash Flow for AVNS at $18.7 million in Q4 2025, -$19.5 million in Q3 2025, and -$9.6 million in Q2 2025.